Armistice Capital, LLC 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:25 pm Purchase | 2025-06-30 | 13G | ZyVersa Therapeutics, Inc. ZVSA | Armistice Capital, LLC | 416,800 4.990% | 131,763 (+46.23%) | Filing |
| 2025-05-15 3:09 pm Purchase | 2025-03-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA | Armistice Capital, LLC | 285,037 9.990% | 285,037 (New Position) | Filing |